Načítá se...
Discordance between testosterone measurement methods in castrated prostate cancer patients
Failure to suppress testosterone below 0.7 nM in castrated prostate cancer patients is associated with poor clinical outcomes. Testosterone levels in castrated patients are therefore routinely measured. Although mass spectrometry is the gold standard used to measure testosterone, most hospitals use...
Uloženo v:
| Vydáno v: | Endocr Connect |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bioscientifica Ltd
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6376995/ https://ncbi.nlm.nih.gov/pubmed/30673630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-18-0476 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|